Hoke TA - Search Results

1

A low-cost, reliable, high-throughput system for rodent behavioral phenotyping in a home cage environment.

Parkison SA, Carlson JD, Chaudoin TR, Hoke TA, Schenk AK, Goulding EH, Pérez LC, Bonasera SJ. Parkison SA, et al. Among authors: hoke ta. Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:2392-5. doi: 10.1109/EMBC.2012.6346445. Annu Int Conf IEEE Eng Med Biol Soc. 2012. PMID: 23366406 Free PMC article.

2

Bonasera SJ, Arikkath J, Boska MD, Chaudoin TR, DeKorver NW, Goulding EH, Hoke TA, Mojtahedzedah V, Reyelts CD, Sajja B, Schenk AK, Tecott LH, Volden TA. Bonasera SJ, et al. Among authors: hoke ta. Aging (Albany NY). 2016 Sep 20;8(9):2153-2181. doi: 10.18632/aging.101040. Aging (Albany NY). 2016. PMID: 27689748 Free PMC article.

3

Validation of Flow Cytometry and Magnetic Bead-Based Methods to Enrich CNS Single Cell Suspensions for Quiescent Microglia.

Volden TA, Reyelts CD, Hoke TA, Arikkath J, Bonasera SJ. Volden TA, et al. Among authors: hoke ta. J Neuroimmune Pharmacol. 2015 Dec;10(4):655-65. doi: 10.1007/s11481-015-9628-7. Epub 2015 Aug 11. J Neuroimmune Pharmacol. 2015. PMID: 26260923 Free PMC article.

4

Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.

Abe F, Dafferner AJ, Donkor M, Westphal SN, Scholar EM, Solheim JC, Singh RK, Hoke TA, Talmadge JE. Abe F, et al. Among authors: hoke ta. Cancer Immunol Immunother. 2010 Jan;59(1):47-62. doi: 10.1007/s00262-009-0719-2. Epub 2009 May 18. Cancer Immunol Immunother. 2010. PMID: 19449184 Free PMC article.

5

Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.

Younos I, Donkor M, Hoke T, Dafferner A, Samson H, Westphal S, Talmadge J. Younos I, et al. Int Immunopharmacol. 2011 Jul;11(7):816-26. doi: 10.1016/j.intimp.2011.02.021. Epub 2011 Mar 2. Int Immunopharmacol. 2011. PMID: 21376153

6

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.

Donkor MK, Lahue E, Hoke TA, Shafer LR, Coskun U, Solheim JC, Gulen D, Bishay J, Talmadge JE. Donkor MK, et al. Among authors: hoke ta. Int Immunopharmacol. 2009 Jul;9(7-8):937-48. doi: 10.1016/j.intimp.2009.03.021. Epub 2009 Apr 9. Int Immunopharmacol. 2009. PMID: 19362167

7

Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB mice.

Abe F, Younos I, Westphal S, Samson H, Scholar E, Dafferner A, Hoke TA, Talmadge JE. Abe F, et al. Among authors: hoke ta. Int Immunopharmacol. 2010 Jan;10(1):140-5. doi: 10.1016/j.intimp.2009.09.023. Epub 2009 Oct 12. Int Immunopharmacol. 2010. PMID: 19833232

8

In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.

Choi SR, Britigan BE, Switzer B, Hoke T, Moran D, Narayanasamy P. Choi SR, et al. Mol Pharm. 2018 Mar 5;15(3):1215-1225. doi: 10.1021/acs.molpharmaceut.7b01036. Epub 2018 Feb 16. Mol Pharm. 2018. PMID: 29421865

9

Pseudomonas Quinolone Signal Induces Oxidative Stress and Inhibits Heme Oxygenase-1 Expression in Lung Epithelial Cells.

Abdalla MY, Hoke T, Seravalli J, Switzer BL, Bavitz M, Fliege JD, Murphy PJ, Britigan BE. Abdalla MY, et al. Infect Immun. 2017 Aug 18;85(9):e00176-17. doi: 10.1128/IAI.00176-17. Print 2017 Sep. Infect Immun. 2017. PMID: 28630072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters